- Lobbying
- Emergent BioSolutions
Lobbying Arrangements Results for 'Emergent Bio Solutions'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details H.R. 2471 - Consolidated Appropriations Act, 2022 |
Emergent BioSolutions, Inc.
|
Mercury Public Affairs, LLC | |||
Details * Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act * No Specific Bill Number. Funding for medical countermeasure enterprise including, Strategic National Stock... |
Emergent Biosolutions Inc.
|
THE OB-C GROUP, LLC | |||
Details FY 2021 appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures for the US government. National Defense Authorization Act COVID 19 provisions |
Dotchin & Associates on behalf of Emergent Biosolutions
|
Nexa Strategies, LLC | |||
Details No lobbying activity in 2020. Client was terminated effective December 31, 2019. |
Emergent BioSolutions, Inc.
|
DAVIS & HARMAN LLP | |||
Details Provide guidance and counsel with regard to federal procurement issues |
Emergent BioSolutions
Biopharmaceutical company |
Barbour Griffith & Rogers, LLC | |||
Details H.R.1300 The First Responder Anthrax Preparedness Act |
Emergent BioSolutions
|
Jim Saxton, LLC | |||
Details Issues related to appropriations funding |
Jackson Park Hospital
Hospital |
mCapitol Management | |||
Details Project Bioshield funding and distribution. |
Emergent Biosolutions Inc.
Vaccine manufacturer. |
DC NAVIGATORS LLC | |||
Details issues related to homeland security, emergency preparedness and response, and strategic national stockpile issues related to homeland security, emergency preparedness and response, and national str... |
Emergent Biosolutions
|
MCAPITOL MANAGEMENT | |||
Details Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advan... |
EMERGENT BIOSOLUTIONS INC.
|
in-house lobbying | |||
Details Health Care Supply Chain. Strategic National Stockpile. PAHPA. Implementation of Inflation Reduction Act. |
Emergent BioSolutions Inc.
|
Todd Strategy Group | |||
Details Providing guidance on development, acquisition and stockpiling of medical countermeasures for the US government. Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA). Funding fo... |
Emergent Biosolutions
|
Capitol Counsel LLC | |||
Details Federal budget and appropriations provisions related to development, acquisition and stockpiling of biodefense vaccines. Implementation of Biomedical Advanced Research and Development Authority (B... |
Emergent Biosolutions Inc.
|
Capitol Legislative Strategies LLC | |||
Details NDAA - provisions related to biological and chemical defense Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines |
Emergent Biosolutions, Inc. (F/K/A Adapt Pharma Inc.)
|
Burrell International Group LLC | |||
Details Issues related to homeland security, emergency preparedness and response, and the strategic national vaccine stockpile. |
Emergent BioSolutions Inc.
biopharmaceutical company |
The Ingram Group LLC | |||
Details HR 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasur... |
Emergent BioSolutions
|
THE ADVOCACY GROUP | |||
Details State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Yea... |
Emergent Biosolutions
|
DOTCHIN & ASSOCIATES, LLC | |||
Details education of federal agencies regarding anthrax vaccine technology |
EMERGENT BIOSOLUTIONS, INC
|
MCKENNA, LONG & ALDRIDGE | |||
Details H.R. 5894 and S. 2624 - Departments of Labor, Health and Human Services, and Education, and Related agencies' Appropriations Act, 2024 - Title II - Department of Health and Human Services - funding... |
EMERGENT BIOSOLUTIONS
|
Hecht Latham Spencer & Associates, Inc., formerly known as Hecht Spencer & Assoc | |||
Details Contracts and/or supply of the military for stockpiling and use of medical countermeasures including anthrax vaccine, IVIG, AIGIV, BIGIV, and chemical WMD decontamination and neutralization lotion ... |
EMERGENT BIOSOLUTIONS, INC. (formerly BioPort Corporation)
|
DALRYMPLE & ASSOCIATES, LLC | |||
Details FY22 Appropriations funding. FY22 NDAA - provisions related to biological and chemical defense and access to naloxone. S.4231 - Preparing for the Next Pandemic Act. Issues related to the developmen... |
Emergent BioSolutions Inc.
|
BLANK ROME GOVERNMENT RELATIONS | |||
Details Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanc... |
Emergent BioSolutions Inc.
|
Ervin Graves Strategy Group, LLC | |||
Details Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanc... |
Emergent BioSolutions
|
ALPINE GROUP PARTNERS, LLC. | |||
Details Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid a... |
Emergent BioSolutions
|
THE NICKLES GROUP, LLC | |||
Details FY 2021 Appropriations Provisions Related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Health and Economic Recovery Omnibus Emergency Solutions ... |
Emergent BioSolutions Inc.
|
Milne, Wiener & Shofe Global Strategies (FKA M & W Government Affairs, LLC) | |||
Details Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanc... |
Emergent BioSolutions Inc.
|
CGCN GROUP, LLC | |||
Details Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advance... |
Emergent BioSolutions Inc.
|
Navigators Global LLC (Formerly DC Navigators, LLC) | |||
Details Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending ... |
Emergent Biosolutions
|
Forbes-Tate | |||
Details Monitor legislative and administrative action related to chemical security, chemical decontamination equipment and the reauthorization of the Chemical Facility Anti-Terrorism Standards law (CFATS).... |
Emergent BioSolutions (formerly Bracco Diagnotics Inc.)
|
DICKSTEIN SHAPIRO LLP |